Company news

CelLBxHealth plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ADR Programme, FDA Update and US Appointment

September 25, 2014

Breast Cancer Collaboration

September 19, 2014

Collaboration with Medical University of Vienna

September 17, 2014

Hamburg-Eppendorf Collaboration

September 8, 2014

Parsortix Granted Second US Patent

August 4, 2014

Parsortix Evaluation

July 22, 2014

Holdings in Company

April 29, 2014

Intellectual Property Update

April 8, 2014

Parsortix FDA Submission

March 17, 2014

Use of Parsortix System with Liver Cancer Patients

February 24, 2014

Parsortix Launch at Circulate Conference in Berlin

February 18, 2014

Cambridge Parsortix Laboratory

January 13, 2014

CE Mark Authorisation

December 17, 2013

Raises?6.2m from Sale of Geomerics

December 13, 2013

Result of 2013 Annual General Meeting

October 31, 2013

Positive Evaluation of Parsortix System

July 25, 2013

Notification of Preliminary Results and Webcast

July 19, 2013

Parsortix Colorectal Cancer Validation

July 8, 2013

Parsortix Manufacturer Appointed

May 28, 2013

Parsortix cell harvesting

May 13, 2013

Parsortix Regulatory Approval Update

May 7, 2013

Parsortix Research Product Launch

February 28, 2013

Director's share transfer

February 15, 2013

Fundraising and Director's Dealings

January 31, 2013

Acolyte Biomedica Settlement

January 15, 2013

Parsortix Cell Recovery

January 14, 2013

Appointment of NED

January 7, 2013

Parsortix Released to Research Partners

December 18, 2012

Business update

December 10, 2012

Appointment of Scientific Advisers

October 18, 2012

Holding(s) in the Company

October 17, 2012

Result of 2012 Annual General Meeting

October 11, 2012

Increased Fundraising

September 3, 2012

Fundraising

July 26, 2012

Notice of Preliminary Results and Conference Call

July 24, 2012

Offer Unconditional for Novocellus' Partner Origio

June 27, 2012

Update Re Novocellus' Partner ORIGIO A/S

June 7, 2012

Geomerics Milestone Payment

May 16, 2012

Parsortix Design Breakthrough

April 30, 2012

Launches New Corporate Website

April 26, 2012

Parsortix Update for Breast Cancer

April 23, 2012

Parsortix Validation for Ovarian Cancer

April 17, 2012

Novocellus Embryosure? Trial Started

April 11, 2012

Geomerics Update

March 26, 2012

Parsortix Validation for Colon Cancer

March 15, 2012

Director Share Transfer

February 28, 2012

Parsortix Research Partnership

February 27, 2012

Second Novocellus Patent

February 22, 2012

Novocellus Update

January 26, 2012

Parsortix Update

January 23, 2012

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 30 decks. Every deck is listed under its year.